Form 4: Claritev Corp: Executive Receives Stock Grant
Statement of Changes in Beneficial Ownership
Albinson Brock, SVP and Chief Accounting Officer of Claritev Corp, was granted 2,956 restricted stock units on March 31, 2026.
Summary
- Albinson Brock, Senior Vice President and Chief Accounting Officer of Claritev Corporation, received a grant of 2,956 restricted stock units (RSUs) on March 31, 2026.
- These RSUs are subject to a vesting schedule, with 25% vesting annually on March 31st of 2027, 2028, 2029, and 2030.
- Following this transaction, Mr. Brock beneficially owns 30,193 shares of Class A common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation event rather than a significant financial or strategic development for the company.
Positives
- Executive compensation through stock grants can align management interests with shareholder value.
- The vesting schedule over four years encourages long-term commitment from the executive.
Negatives
- The filing does not provide details on the valuation of the granted RSUs at the time of the award, only that they were acquired at a price of $0.
Risks
- The value of the granted RSUs is subject to the future performance of Claritev Corporation's stock price.
- Potential for executive departure before full vesting could result in forfeiture of unvested RSUs.
Future Outlook
The restricted stock units granted will vest over a four-year period, with 25% vesting annually from March 31, 2027, through March 31, 2030. The future value of these units is contingent on the company's stock performance.
Industry Context
StockSavvy.ai notes that grants of restricted stock units are a common form of executive compensation in the technology sector, designed to incentivize long-term performance and retention. This aligns with industry practices for companies like Claritev Corp.
Stakeholder Impact
- Shareholders: The grant of RSUs is a form of compensation that dilutes existing ownership slightly, but it is intended to align executive interests with long-term shareholder value.
- Employees: This filing pertains to executive compensation and does not directly impact other employees.
- Management: Albinson Brock's compensation is enhanced by this stock grant, contingent on future performance.
Next Steps
- Vesting of restricted stock units on March 31st of each year from 2027 to 2030.
- Continued beneficial ownership of Claritev Corp Class A common stock by Albinson Brock.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of earliest transaction; grant date of restricted stock units. |
| 03/31/2027 | First vesting date for 25% of the granted restricted stock units. |
| 03/31/2028 | Second vesting date for 25% of the granted restricted stock units. |
| 03/31/2029 | Third vesting date for 25% of the granted restricted stock units. |
| 03/31/2030 | Final vesting date for the remaining 25% of the granted restricted stock units. |
| 04/02/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Form 4, SEC Filing, Claritev Corp, CTEV, Stock Grant, Restricted Stock Units, RSU, Executive Compensation, Beneficial Ownership, Albinson Brock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.